Exscientia
is an England-based biotech company that develops an AI-driven platform offering solutions such as drug discovery and development for the pharmaceutical industry... Read moreExscientia
is an England-based biotech company that develops an AI-driven platform offering solutions such as drug discovery and development for the pharmaceutical industry... Read more
News
Nov 13, 2024
centralcharts
Press Release: Exscientia : Recursion and Exscientia Shareholders Approve the Proposed Combination
Aug 28, 2024
FinanzNachrichten
Exscientia: Exscientia plc: Exscientia to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
Aug 18, 2024
Americanbankingnews
Exscientia: Exscientia (NASDAQ:EXAI) Releases Earnings Results
Aug 08, 2024
AsiaNet Pakistan
Press Release: Exscientia : Recursion and Exscientia Enter Definitive Agreement to Create a Global Technology-Enabled Drug Discovery Leader with End-to-End Capabilities
Jul 10, 2024
RTTNews
Exscientia: Exscientia Extends Collaboration With AWS To Use AI And Machine Learning Services
Jun 25, 2024
PR-Inside
Press Release: Exscientia : Exscientia Plc Investors With Losses Are Encouraged By The Schall Law ...
Jun 25, 2024
MarketScreener
Exscientia: EXAI Today Is The Last Day that Investors can Lead Exscientia plc Fraud Lawsuit
Jun 25, 2024
Benzinga
Exscientia: DEADLINE ALERT for EXAI, AKRO, and MBUU: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
Jun 24, 2024
PR-Inside
Press Release: Exscientia : FINAL EXAI DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Exscientia ...
Jun 22, 2024
PR-Inside
Press Release: Exscientia : The Schall Law Firm Urges Investors Who Have Suffered Losses In Exscientia ...
Exscientia Competitors
1
2
3
4
5
6
7
8
9
10